Evoke Pharma, Inc. - Common Shares (EVOK)

CUSIP: 30049G203

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class
Equity / Common Shares
Shares outstanding
1,582,162
Total 13F shares
60,640
Share change
-1,780
Total reported value
$161,234
Price per share
$2.68
Number of holders
10
Value change
-$4,397
Number of buys
4
Number of sells
3

Security key

30049G203

Report period

Q4 2022

Institutions

10

Top holders

10

Ownership snapshot

Top shareholders of EVOK - Evoke Pharma, Inc. - Common Shares (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder
VANGUARD GROUP INC
13D/G signal
Evidence rows
8
Latest as of
30 Sep 2022
13F 3/4/5 Lead comparable stake: 1.9%
Holder Evidence Ownership % Position 12M Net Δ As of
VANGUARD GROUP INC
13F
Company
13F
1.9%
$56,000
29,851 shares
30 Sep 2022
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
13F
1.3%
$39,000
20,894 shares
30 Sep 2022
BlackRock Finance, Inc.
13F
Company
13F
0.5%
$15,000
7,977 shares
30 Sep 2022
Tower Research Capital LLC (TRC)
13F
Company
13F
0.14%
$4,000
2,248 shares
30 Sep 2022
UBS Group AG
13F
Company
13F
0.07%
$2,000
1,107 shares
30 Sep 2022
GROUP ONE TRADING LLC
13F
Company
13F
0.02%
$1,000
338 shares
30 Sep 2022
Federation Des Caisses Desjardins du Quebec
13F
Individual
13F
0%
$9
5 shares
30 Sep 2022
Ann D. Rhoads
3/4/5
Director
class O/S missing
61,750 shares
05 May 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
10
Shares
60,640
Rows loaded
10
Investor Option Weight % Change % Reported value * Price Shares Share Change Activity Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. An asterisk next to the price means the price is likely invalid.

Compare Q4 2022 vs Q3 2022 Across Filers

Q3 2022 holders
7
Q4 2022 holders
10
Holder diff
3
Investor Q3 2022 Shares Q4 2022 Shares Share Diff Share Chg % Q3 2022 value Q4 2022 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .